A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis
Main Authors: | Knevel, Rachel, de Rooy, Diederik PC, Saxne, Tore, Lindqvist, Elisabet, Leijsma, Martha K, Daha, Nina A, Koeleman, Bobby PC, Tsonaka, Roula, Houwing-Duistermaat, Jeanine J, Schonkeren, Joris JM, Toes, Rene EM, Huizinga, Tom WJ, Brouwer, Elisabeth, Wilson, Anthony G, van der Helm-van Mil, Annette HM |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060386/ |
Similar Items
-
Does pathway analysis make it easier for common variants to tag rare ones?
by: Uh, Hae-Won, et al.
Published: (2011) -
Pathway analysis for family data using nested random-effects models
by: Houwing-Duistermaat, Jeanine J, et al.
Published: (2011) -
Can anti-cyclic citrullinated peptide antibody-negative RA be subdivided into clinical subphenotypes?
by: De Rooy, Diederik PC, et al.
Published: (2011) -
Combining information from linkage and association mapping for next-generation sequencing longitudinal family data
by: Balliu, Brunilda, et al.
Published: (2014) -
Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study
by: van Steenbergen, Hanna W, et al.
Published: (2015)